Home › Bids
› Innovation Grants to Nurture Initial Translational Efforts (
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)
This grant opportunity, PAR-25-059 (CFDA: 93.853), seeks to fund innovative projects focused on assay development and neurotherapeutic agent identification. The IGNITE program aims to nurture initial translational efforts, but clinical trials are not allowed under this R61/R33 mechanism.
Want the full details?
Sign up free to see the agency name and the original bid posting link, plus contracting-officer contacts and AI response outlines. Every feature is free through December 31, 2026.